Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Romain, Senal"'
Autor:
Jérôme Solassol, Pierre Brousset, Etienne Coyaud, Sylvain Godreuil, Abdelali Bouidioua, Benoit Roch, Jean-Louis Pujol, Xavier Quantin, Isabelle Rouquette, Romain Senal, Julien Mazieres, Julie A. Vendrell
Purpose:The detection of preexisting EGFRT790M subclones and the assessment of their clinical significance in the pretreatment of patients with EGFRT790M non–small cell lung cancer (NSCLC) remain unclear.Experimental Design:A total of 179 tumor sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ae5bfb4ae0374672fb199f0fdd465e
https://doi.org/10.1158/1078-0432.c.6527717
https://doi.org/10.1158/1078-0432.c.6527717
Autor:
Eric Frouin, Thierry Maudelonde, Romain Senal, Marion Larrieux, Valérie Costes, Sylvain Godreuil, Julie A Vendrell, Jérôme Solassol
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0158698 (2016)
Genotyping BRAF in melanoma samples is often challenging. The presence of melanin greatly interferes with thermostable DNA polymerases and/or nucleic acids in traditional polymerase chain reaction (PCR)-based methods. In the present work, we evaluate
Externí odkaz:
https://doaj.org/article/58b4574270db4489a39780360ccaf88f
Autor:
Julie A. Vendrell, Jérôme Solassol, Isabelle Rouquette, Pierre Brousset, Etienne Coyaud, Romain Senal, Abdelali Bouidioua, Benoit Roch, Xavier Quantin, Sylvain Godreuil, Julien Mazieres, Jean-Louis Pujol
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2019, 25 (14), pp.4280-4289. ⟨10.1158/1078-0432.CCR-18-2683⟩
Clinical Cancer Research, American Association for Cancer Research, 2019, 25 (14), pp.4280-4289. ⟨10.1158/1078-0432.CCR-18-2683⟩
Purpose: The detection of preexisting EGFRT790M subclones and the assessment of their clinical significance in the pretreatment of patients with EGFRT790M non–small cell lung cancer (NSCLC) remain unclear. Experimental Design: A total of 179 tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca07306ab4218aa8d964f8ccdec1b6b
https://hal.umontpellier.fr/hal-02448987
https://hal.umontpellier.fr/hal-02448987
Autor:
Romain Senal, Marion Larrieux, Jérôme Solassol, Julie A. Vendrell, Alain Mangé, David Grand, Eleftherios P. Diamandis, Xavier Quantin, Patricia Audran
Publikováno v:
Clinical Chemistry and Laboratory Medicine
Clinical Chemistry and Laboratory Medicine, De Gruyter, 2018, 56 (9), pp.e243-e246. ⟨10.1515/cclm-2017-0967⟩
Clinical Chemistry and Laboratory Medicine, De Gruyter, 2018, 56 (9), pp.e243-e246. ⟨10.1515/cclm-2017-0967⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c135827010398d9ca0ab82132763adf2
https://hal.umontpellier.fr/hal-02292348
https://hal.umontpellier.fr/hal-02292348
Autor:
Julie A, Vendrell, Julien, Mazieres, Romain, Senal, Isabelle, Rouquette, Xavier, Quantin, Jean-Louis, Pujol, Benoit, Roch, Abdelali, Bouidioua, Sylvain, Godreuil, Etienne, Coyaud, Pierre, Brousset, Jérôme, Solassol
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(14)
The detection of preexistingA total of 179 tumor samples from patients treated or not with a first-generation tyrosine kinase inhibitor (TKI) was analyzed. The presence of ultra-low levels of preexisting EGFRWith a ddPCR linear performance of 0.999 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4bbca6e1579ff0832ad3b9d999d0f70
https://pubmed.ncbi.nlm.nih.gov/30936123
https://pubmed.ncbi.nlm.nih.gov/30936123
Autor:
Thierry Maudelonde, Eric Frouin, Sylvain Godreuil, Jérôme Solassol, Julie A. Vendrell, Romain Senal, Valérie Costes, Marion Larrieux
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (7), pp.e0158698. ⟨10.1371/journal.pone.0158698⟩
PLoS ONE, Vol 11, Iss 7, p e0158698 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (7), pp.e0158698. ⟨10.1371/journal.pone.0158698⟩
PLoS ONE, Vol 11, Iss 7, p e0158698 (2016)
International audience; Genotyping BRAF in melanoma samples is often challenging. The presence of melanin greatly interferes with thermostable DNA polymerases and/or nucleic acids in traditional polymerase chain reaction (PCR)-based methods. In the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f1fed71ea79be204fb8762ea1e3a12
https://hal.umontpellier.fr/hal-01844424/document
https://hal.umontpellier.fr/hal-01844424/document
Autor:
Simon Thezenas, Frédéric Bibeau, Pierre-Jean Lamy, William Jacot, Anne-Claire Laberenne, Jean-Pierre Bleuse, Gilles Romieu, Evelyne Lopez-Crapez, Cathy Viglianti, Romain Senal
Publikováno v:
BMC Cancer
Background: Poly(adenosine diphosphate–ribose) polymerase 1 (PARP-1) and the balance between BRCA1 and 53BP1 play a key role in the DNA repair and cell stress response. PARP inhibitors show promising clinical activity in metastatic triple negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1017abf9316c5f678dc988343693db27
https://pubmed.ncbi.nlm.nih.gov/24191908
https://pubmed.ncbi.nlm.nih.gov/24191908
Autor:
Frédéric Bibeau, Frédéric Fina, William Jacot, Gilles Romieu, Pierre-Jean Lamy, Romain Senal, Simon Thezenas, Evelyne Lopez-Crapez
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, vol. 13, no. 6, pp. R133
Breast Cancer Research, vol. 13, no. 6, pp. R133
INTRODUCTION: Triple-negative breast cancers (TNBCs) are characterised by lack of expression of hormone receptors and epidermal growth factor receptor 2 (HER-2). As they frequently express epidermal growth factor receptors (EGFRs), anti-EGFR therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1376dfda418ab987363d7989b12961f9
https://doi.org/10.1186/bcr3079
https://doi.org/10.1186/bcr3079